Literature DB >> 27402972

The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia.

Hongming Zhu1, Jiong Hu1, Li Chen1, Wei Zhou2, Xiaoyang Li1, Lining Wang1, Xia Zhao1, Yunxiang Zhang1, Huijin Zhao1, Aihua Wang1, Yú Chen1, Huiping Sun1, Qiusheng Chen1, Yù Chen1, Weili Zhao1, Jianqing Mi1, Zhixiang Shen1, Zhenyi Wang1, Zhu Chen1, Saijuan Chen1, Junmin Li1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27402972     DOI： 10.1182/blood-2016-02-699439

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  17 in total

Review 1.  Old dog, new trick: Trivalent arsenic as an immunomodulatory drug.

Authors:  Yishan Ye; Béatrice Gaugler; Mohamad Mohty; Florent Malard
Journal:  Br J Pharmacol       Date:  2020-03-12       Impact factor: 8.739

2.  Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).

Authors:  Li Chen; Hong-Ming Zhu; Yan Li; Qi-Fa Liu; Yu Hu; Jian-Feng Zhou; Jie Jin; Jian-Da Hu; Ting Liu; De-Pei Wu; Jie-Ping Chen; Yong-Rong Lai; Jian-Xiang Wang; Juan Li; Jian-Yong Li; Xin Du; Xin Wang; Ming-Zhen Yang; Jin-Song Yan; Gui-Fang Ouyang; Li Liu; Ming Hou; Xiao-Jun Huang; Xiao-Jing Yan; Dan Xu; Wei-Ming Li; Deng-Ju Li; Yin-Jun Lou; Zheng-Jun Wu; Ting Niu; Ying Wang; Xiao-Yang Li; Jian-Hua You; Hui-Jin Zhao; Yú Chen; Yang Shen; Qiu-Sheng Chen; Yù Chen; Jian Li; Bing-Shun Wang; Wei-Li Zhao; Jian-Qing Mi; Kan-Kan Wang; Jiong Hu; Zhu Chen; Sai-Juan Chen; Jun-Min Li
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

Review 3.  Treatment for relapsed acute promyelocytic leukemia.

Authors:  Masamitsu Yanada
Journal:  Ann Hematol       Date:  2022-08-16       Impact factor: 4.030

Review 4.  Current views on the genetic landscape and management of variant acute promyelocytic leukemia.

Authors:  Xiang Zhang; Jiewen Sun; Wenjuan Yu; Jie Jin
Journal:  Biomark Res       Date:  2021-05-06

Review 5.  Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives.

Authors:  Derek McCulloch; Christina Brown; Harry Iland
Journal:  Onco Targets Ther       Date:  2017-03-14       Impact factor: 4.147

6.  Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.

Authors:  Xuzhao Zhang; Jinliang Chen; Weiqin Wang; Xian Li; Yanbin Tan; Xiaohong Zhang; Wenbin Qian
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

7.  Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide.

Authors:  Akiko Hashimoto; Yasuhiro Tanaka; Isaku Shinzato
Journal:  Clin Case Rep       Date:  2021-07-23

8.  Incident adverse events following therapy for acute promyelocytic leukemia.

Authors:  Peter Geon Kim; Kelly Bridgham; Evan C Chen; Mahesh K Vidula; Olga Pozdnyakova; Andrew M Brunner; Amir T Fathi
Journal:  Leuk Res Rep       Date:  2018-05-05

9.  Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors.

Authors:  Zhifen Cui; Yu Zhang; Kai Xia; Qinglong Yan; Huating Kong; Jichao Zhang; Xiaolei Zuo; Jiye Shi; Lihua Wang; Ying Zhu; Chunhai Fan
Journal:  Nat Commun       Date:  2018-10-19       Impact factor: 14.919

10.  Arsenic sulfide induces RAG1-dependent DNA damage for cell killing by inhibiting NFATc3 in gastric cancer cells.

Authors:  Ting Kang; Maolin Ge; Ruiheng Wang; Zhen Tan; Xiuli Zhang; Chuanying Zhu; Han Liu; Siyu Chen
Journal:  J Exp Clin Cancer Res       Date:  2019-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.